WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks ®, the largest ambulatory cloud EHR, today announced that Advocare, LLC — one of Pennsylvania and New Jersey’s largest independently physician-owned ...

Westborough, Massachusetts-based EMR provider eClinicalWorks has added telehealth capabilities to its mobile app. The company’s device-agnostic platform also provides tools for practice management and ...

Specialty care is a vital component of a patient’s overall healthcare journey, requiring close collaboration between providers. More than one-third of patients in the US are referred to a specialist ...

EClinicalWorks, a cloud-based vendor of electronic health record and practice management systems for small clinics, hospitals and large health systems, will have a large presence at the HIMSS24 Global ...

ORLANDO, Fla.–(BUSINESS WIRE)–eClinicalWorks ®, the largest ambulatory cloud EHR, opened its 2022 National Conference today and announced its year-to-date revenue and customer base growth. With 23 ...

WESTBOROUGH, Mass., July 09, 2026--eClinicalWorks®, one of the largest ambulatory cloud EHR providers, announced that Joi Life Wellness, a neurology practice in Georgia specializing in cognitive ...

Partnership enables doctors to more effortlessly capture patient encounters using Sunoh.ai Bethesda, MD and Westborough, MA, July 23, 2024 (GLOBE NEWSWIRE) -- Aledade, the nation's largest network of ...

After moving its EHR system to Microsoft Azure, eClinicalWorks is integrating ChatGPT and other OpenAI tools into its EHR and practice management systems. The company aims for AI tools to reduce ...

Health IT vendor eClinicalWorks recently issued a safety warning to clinicians, pharmacists, patients and families. eClinicalWorks claimed it “periodically [identifies] potential patient safety risks ...

eClinicalWorks, a Westboro-based developer of medical software, was chosen by Indiana-based Hendricks Regional Health Medical Group (HRHMG) to streamline internal operations. HRHMG will use ...

South Korea’s Chong Kun Dang Pharmaceuticals Corp. said that it struck a deal potentially worth $1.3 billion with Swiss pharma giant Novartis AG for its CKD-510... The U.S. FDA approved Takeda ...